Nathan Weinstein
Stock Analyst at Aegis Capital
(0.28)
# 4,389
Out of 5,148 analysts
59
Total ratings
13.79%
Success rate
-24.81%
Average return
Main Sectors:
Stocks Rated by Nathan Weinstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVGN Evogene | Maintains: Buy | $100 → $80 | $0.86 | +9,159.26% | 2 | Sep 12, 2022 | |
| DRIO DarioHealth | Maintains: Buy | $400 → $300 | $10.75 | +2,690.70% | 6 | Aug 18, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $9 → $6 | $0.20 | +2,860.04% | 5 | Aug 15, 2022 | |
| IMUX Immunic | Maintains: Buy | $40 → $35 | $1.06 | +3,201.89% | 2 | Aug 8, 2022 | |
| STXS Stereotaxis | Initiates: Buy | $6 | $2.22 | +170.27% | 1 | Jul 12, 2022 | |
| ORMP Oramed Pharmaceuticals | Maintains: Buy | $35 → $30 | $3.34 | +798.20% | 5 | May 16, 2022 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $10 | $12.57 | -20.45% | 1 | Mar 29, 2022 | |
| MDWD MediWound | Maintains: Buy | $63 → $49 | $17.44 | +180.96% | 4 | Mar 21, 2022 | |
| ENVB Enveric Biosciences | Downgrades: Hold | $63,000 → $1,800 | $2.25 | +79,900.00% | 2 | Mar 8, 2022 | |
| CING Cingulate | Initiates: Buy | $2,160 | $6.54 | +32,927.52% | 1 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $1.96 | +6,022.45% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $0.60 | +1,566.67% | 2 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $26.21 | +113.66% | 2 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $27 | $3.68 | +633.70% | 3 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $0.75 | +4,571.03% | 4 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.37 | +775.91% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $27.39 | +173.82% | 1 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $88 | $2.03 | +4,234.98% | 3 | Oct 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $0.60 | +30,086.15% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $135 | $10.23 | +1,219.65% | 3 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $6.54 | +114.07% | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $220 | $13.93 | +1,479.33% | 7 | May 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8.5 | $2.96 | +187.16% | 1 | Mar 23, 2020 |
Evogene
Sep 12, 2022
Maintains: Buy
Price Target: $100 → $80
Current: $0.86
Upside: +9,159.26%
DarioHealth
Aug 18, 2022
Maintains: Buy
Price Target: $400 → $300
Current: $10.75
Upside: +2,690.70%
VolitionRx
Aug 15, 2022
Maintains: Buy
Price Target: $9 → $6
Current: $0.20
Upside: +2,860.04%
Immunic
Aug 8, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $1.06
Upside: +3,201.89%
Stereotaxis
Jul 12, 2022
Initiates: Buy
Price Target: $6
Current: $2.22
Upside: +170.27%
Oramed Pharmaceuticals
May 16, 2022
Maintains: Buy
Price Target: $35 → $30
Current: $3.34
Upside: +798.20%
Trevi Therapeutics
Mar 29, 2022
Initiates: Buy
Price Target: $10
Current: $12.57
Upside: -20.45%
MediWound
Mar 21, 2022
Maintains: Buy
Price Target: $63 → $49
Current: $17.44
Upside: +180.96%
Enveric Biosciences
Mar 8, 2022
Downgrades: Hold
Price Target: $63,000 → $1,800
Current: $2.25
Upside: +79,900.00%
Cingulate
Jan 11, 2022
Initiates: Buy
Price Target: $2,160
Current: $6.54
Upside: +32,927.52%
Dec 7, 2021
Initiates: Buy
Price Target: $120
Current: $1.96
Upside: +6,022.45%
Nov 1, 2021
Maintains: Buy
Price Target: $9 → $10
Current: $0.60
Upside: +1,566.67%
Sep 9, 2021
Maintains: Buy
Price Target: $60 → $56
Current: $26.21
Upside: +113.66%
Aug 17, 2021
Maintains: Buy
Price Target: $26 → $27
Current: $3.68
Upside: +633.70%
Jun 7, 2021
Maintains: Buy
Price Target: $40 → $35
Current: $0.75
Upside: +4,571.03%
Mar 22, 2021
Initiates: Buy
Price Target: $12
Current: $1.37
Upside: +775.91%
Jan 26, 2021
Initiates: Buy
Price Target: $75
Current: $27.39
Upside: +173.82%
Oct 19, 2020
Maintains: Buy
Price Target: $104 → $88
Current: $2.03
Upside: +4,234.98%
Oct 8, 2020
Initiates: Buy
Price Target: $180
Current: $0.60
Upside: +30,086.15%
Aug 3, 2020
Maintains: Buy
Price Target: $195 → $135
Current: $10.23
Upside: +1,219.65%
Jul 13, 2020
Initiates: Buy
Price Target: $14
Current: $6.54
Upside: +114.07%
May 4, 2020
Maintains: Buy
Price Target: $180 → $220
Current: $13.93
Upside: +1,479.33%
Mar 23, 2020
Initiates: Buy
Price Target: $8.5
Current: $2.96
Upside: +187.16%